Agios Pharmaceuticals
AGIO
AGIO
223 hedge funds and large institutions have $1.97B invested in Agios Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 85 increasing their positions, 70 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
22% less call options, than puts
Call options by funds: $9.02M | Put options by funds: $11.5M
24% less capital invested
Capital invested by funds: $2.57B → $1.97B (-$608M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
223
Holding in Top 10
1
Calls
$9.02M
Puts
$11.5M
Top Buyers
| 1 | +$49.3M | |
| 2 | +$46.7M | |
| 3 | +$9.96M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$9.08M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.73M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$22.9M | |
| 3 | -$20.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$13.4M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$12.7M |